Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.
Davey RT Jr, Chaitt DG, Reed GF, Freimuth WW, Herpin BR, Metcalf JA, Eastman PS, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Boyle J, Coleman S, Cox SR, Wathen L, Daenzer CL, Lane HC.
Davey RT Jr, et al. Among authors: walker re.
Antimicrob Agents Chemother. 1996 Jul;40(7):1657-64. doi: 10.1128/AAC.40.7.1657.
Antimicrob Agents Chemother. 1996.
PMID: 8807058
Free PMC article.
Clinical Trial.